Inhibitory effects of interleukin-4 on human renal cell carcinoma cells in vitro

In combination with interferon-α, tumor necrosis factor-α or interleukin-2

Jun Cheon, Dong Joon Chung, Je-Jong Kim, Sung Kun Koh, Jeongwon Sohn

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Immune cytokines have been shown to play important roles in regulating the growth of neoplastic cells, as well as the function of immune cells. The present study assessed the effects of interleukin (IL)-4 alone, and in combination with recombinant interferon (IFN)-α2b, or with IL-2, or with tumor necrosis factor (TNF)-α on the in vitro proliferation of human renal cell carcinoma (RCC) cell-lines. Methods: Growth-inhibitory effects of IL-4 alone, and in combination with other cytokines, on three human RCC cell-lines, Caki-1, CURC-II, and A-498, were measured by the [3H]thymidine incorporation assay. Results: IL-4 inhibited proliferation of all three human RCC cell-lines (P < 0.001). The maximum growth inhibition of RCC cell-lines by IL-4 alone was observed at the concentration of 1 to 3 ng/mL, depending on the cell-line. Antihuman IL-4 antisera was able to reverse the growth-inhibitory effects of IL-4 on Caki-1 in a dose-dependent manner, proving that the growth inhibition was mediated by IL-4 itself, When other cytokines were added in combination with IL-4, only IFN-α2b resulted in significant additional growth inhibition (P < 0.005). However, when the proliferation was compared to that of RCC cells that were not treated with any cytokine, all combinations produced marked growth inhibition. Conclusion: Our data suggest that IL-4 alone, or in combination with IFN-α2b, can be used to develop new strategies for treatment of human RCC.

Original languageEnglish
Pages (from-to)196-201
Number of pages6
JournalInternational Journal of Urology
Volume3
Issue number3
Publication statusPublished - 1996 Jul 15

Fingerprint

Renal Cell Carcinoma
Interleukin-4
Interferons
Interleukin-2
Tumor Necrosis Factor-alpha
Growth
Cell Line
Cytokines
In Vitro Techniques
Thymidine
Immune Sera

Keywords

  • Growth inhibition
  • Human renal cell carcinoma cell-line
  • Interferon-α2b
  • Interleukin-4
  • Tumor necrosis factor-α

ASJC Scopus subject areas

  • Urology

Cite this

Inhibitory effects of interleukin-4 on human renal cell carcinoma cells in vitro : In combination with interferon-α, tumor necrosis factor-α or interleukin-2. / Cheon, Jun; Chung, Dong Joon; Kim, Je-Jong; Koh, Sung Kun; Sohn, Jeongwon.

In: International Journal of Urology, Vol. 3, No. 3, 15.07.1996, p. 196-201.

Research output: Contribution to journalArticle

@article{592fafd3951f4fdfb6e9fa3d223ad16b,
title = "Inhibitory effects of interleukin-4 on human renal cell carcinoma cells in vitro: In combination with interferon-α, tumor necrosis factor-α or interleukin-2",
abstract = "Background: Immune cytokines have been shown to play important roles in regulating the growth of neoplastic cells, as well as the function of immune cells. The present study assessed the effects of interleukin (IL)-4 alone, and in combination with recombinant interferon (IFN)-α2b, or with IL-2, or with tumor necrosis factor (TNF)-α on the in vitro proliferation of human renal cell carcinoma (RCC) cell-lines. Methods: Growth-inhibitory effects of IL-4 alone, and in combination with other cytokines, on three human RCC cell-lines, Caki-1, CURC-II, and A-498, were measured by the [3H]thymidine incorporation assay. Results: IL-4 inhibited proliferation of all three human RCC cell-lines (P < 0.001). The maximum growth inhibition of RCC cell-lines by IL-4 alone was observed at the concentration of 1 to 3 ng/mL, depending on the cell-line. Antihuman IL-4 antisera was able to reverse the growth-inhibitory effects of IL-4 on Caki-1 in a dose-dependent manner, proving that the growth inhibition was mediated by IL-4 itself, When other cytokines were added in combination with IL-4, only IFN-α2b resulted in significant additional growth inhibition (P < 0.005). However, when the proliferation was compared to that of RCC cells that were not treated with any cytokine, all combinations produced marked growth inhibition. Conclusion: Our data suggest that IL-4 alone, or in combination with IFN-α2b, can be used to develop new strategies for treatment of human RCC.",
keywords = "Growth inhibition, Human renal cell carcinoma cell-line, Interferon-α2b, Interleukin-4, Tumor necrosis factor-α",
author = "Jun Cheon and Chung, {Dong Joon} and Je-Jong Kim and Koh, {Sung Kun} and Jeongwon Sohn",
year = "1996",
month = "7",
day = "15",
language = "English",
volume = "3",
pages = "196--201",
journal = "International Journal of Urology",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Inhibitory effects of interleukin-4 on human renal cell carcinoma cells in vitro

T2 - In combination with interferon-α, tumor necrosis factor-α or interleukin-2

AU - Cheon, Jun

AU - Chung, Dong Joon

AU - Kim, Je-Jong

AU - Koh, Sung Kun

AU - Sohn, Jeongwon

PY - 1996/7/15

Y1 - 1996/7/15

N2 - Background: Immune cytokines have been shown to play important roles in regulating the growth of neoplastic cells, as well as the function of immune cells. The present study assessed the effects of interleukin (IL)-4 alone, and in combination with recombinant interferon (IFN)-α2b, or with IL-2, or with tumor necrosis factor (TNF)-α on the in vitro proliferation of human renal cell carcinoma (RCC) cell-lines. Methods: Growth-inhibitory effects of IL-4 alone, and in combination with other cytokines, on three human RCC cell-lines, Caki-1, CURC-II, and A-498, were measured by the [3H]thymidine incorporation assay. Results: IL-4 inhibited proliferation of all three human RCC cell-lines (P < 0.001). The maximum growth inhibition of RCC cell-lines by IL-4 alone was observed at the concentration of 1 to 3 ng/mL, depending on the cell-line. Antihuman IL-4 antisera was able to reverse the growth-inhibitory effects of IL-4 on Caki-1 in a dose-dependent manner, proving that the growth inhibition was mediated by IL-4 itself, When other cytokines were added in combination with IL-4, only IFN-α2b resulted in significant additional growth inhibition (P < 0.005). However, when the proliferation was compared to that of RCC cells that were not treated with any cytokine, all combinations produced marked growth inhibition. Conclusion: Our data suggest that IL-4 alone, or in combination with IFN-α2b, can be used to develop new strategies for treatment of human RCC.

AB - Background: Immune cytokines have been shown to play important roles in regulating the growth of neoplastic cells, as well as the function of immune cells. The present study assessed the effects of interleukin (IL)-4 alone, and in combination with recombinant interferon (IFN)-α2b, or with IL-2, or with tumor necrosis factor (TNF)-α on the in vitro proliferation of human renal cell carcinoma (RCC) cell-lines. Methods: Growth-inhibitory effects of IL-4 alone, and in combination with other cytokines, on three human RCC cell-lines, Caki-1, CURC-II, and A-498, were measured by the [3H]thymidine incorporation assay. Results: IL-4 inhibited proliferation of all three human RCC cell-lines (P < 0.001). The maximum growth inhibition of RCC cell-lines by IL-4 alone was observed at the concentration of 1 to 3 ng/mL, depending on the cell-line. Antihuman IL-4 antisera was able to reverse the growth-inhibitory effects of IL-4 on Caki-1 in a dose-dependent manner, proving that the growth inhibition was mediated by IL-4 itself, When other cytokines were added in combination with IL-4, only IFN-α2b resulted in significant additional growth inhibition (P < 0.005). However, when the proliferation was compared to that of RCC cells that were not treated with any cytokine, all combinations produced marked growth inhibition. Conclusion: Our data suggest that IL-4 alone, or in combination with IFN-α2b, can be used to develop new strategies for treatment of human RCC.

KW - Growth inhibition

KW - Human renal cell carcinoma cell-line

KW - Interferon-α2b

KW - Interleukin-4

KW - Tumor necrosis factor-α

UR - http://www.scopus.com/inward/record.url?scp=0029975490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029975490&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 196

EP - 201

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - 3

ER -